ONCOTARGET

Publications

  1. 2020
  2. Expression and serum levels of the neural cell adhesion molecule L1-like protein (CHL1) in gastrointestinal stroma tumors (GIST) and its prognostic power

    Karstens, K-F., Bellon, E., Polonski, A., Wolters-Eisfeld, G., Melling, N., Reeh, M., Izbicki, J. R. & Tachezy, M., 31.03.2020, In: ONCOTARGET. 11, 13, p. 1131-1140 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinoma

    Jacobsen, F., Kohsar, J., Gebauer, F., Kluth, M., Hube-Magg, C., Simon, R., Bockhorn, M., Hinsch, A., Burandt, E., Lübke, A. M., Steurer, S., Tachezy, M., Sauter, G., Izbicki, J. R., Wilczak, W. & Melling, N., 24.03.2020, In: ONCOTARGET. 11, 12, p. 1007-1016 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes

    Büscheck, F., Fraune, C., Simon, R., Kluth, M., Hube-Magg, C., Möller-Koop, C., Sarper, I., Ketterer, K., Henke, T., Eichelberg, C., Dahlem, R., Wilczak, W., Sauter, G., Fisch, M., Eichenauer, T. & Rink, M., 21.01.2020, In: ONCOTARGET. 11, 3, p. 237-249 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. TP53 co-mutations in EGFR mutated patients in NSCLC stage IV: A strong predictive factor of ORR, PFS and OS in EGFR mt+ NSCLC

    Roeper, J., Falk, M., Chalaris-Rißmann, A., Lueers, A. C., Ramdani, H., Wedeken, K., Stropiep, U., Diehl, L., Tiemann, M., Heukamp, L. C., Otto-Sobotka, F. & Griesinger, F., 21.01.2020, In: ONCOTARGET. 11, 3, p. 250-264 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. 2019
  7. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

    Steurer, S., Schwemmer, L., Hube-Magg, C., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Clauditz, T. S., Luebke, A. M., Simon, R., Sauter, G., Izbicki, J., Schroeder, C., Schlomm, T., Huland, H., Heinzer, H., Haese, A., Graefen, M., Göbel, C., Weidemann, S., Lebok, P., Dum, D., Fraune, C., Minner, S. & Meiners, J., 24.12.2019, In: ONCOTARGET. 10, 67, p. 7096-7111 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastoma

    Dührsen, L., Hartfuß, S., Hirsch, D., Geiger, S., Maire, C. L., Sedlacik, J., Guenther, C., Westphal, M., Lamszus, K., Hermann, F. G. & Schmidt, N. O., 22.10.2019, In: ONCOTARGET. 10, 58, p. 6049-6061 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

    Bonk, S., Kluth, M., Hube-Magg, C., Polonski, A., Soekeland, G., Makropidi-Fraune, G., Möller-Koop, C., Witt, M., Luebke, A. M., Hinsch, A., Burandt, E., Steurer, S., Clauditz, T. S., Schlomm, T., Perez, D., Graefen, M., Heinzer, H., Huland, H., Izbicki, J. R., Wilczak, W., Minner, S., Sauter, G. & Simon, R., 10.09.2019, In: ONCOTARGET. 10, 52, p. 5439-5453 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy

    Schroeder, C., Navid-Hill, E., Meiners, J., Hube-Magg, C., Kluth, M., Makrypidi-Fraune, G., Simon, R., Büscheck, F., Luebke, A. M., Goebel, C., Lang, D. S., Weidemann, S., Neubauer, E., Hinsch, A., Jacobsen, F., Lebok, P., Michl, U., Pehrke, D., Huland, H., Graefen, M., Schlomm, T., Sauter, G. & Höflmayer, D., 13.08.2019, In: ONCOTARGET. 10, 48, p. 4973-4986 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile

    Reidel, V., Kauschinger, J., Hauch, R. T., Müller-Thomas, C., Nadarajah, N., Burgkart, R., Schmidt, B., Hempel, D., Jacob, A., Slotta-Huspenina, J., Höckendorf, U., Peschel, C., Kern, W., Haferlach, T., Götze, K. S., Jilg, S. & Jost, P. J., 03.04.2019, In: ONCOTARGET. 9, 25, p. 17270-17281 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

    Eichenauer, T., Hussein, M., Hube-Magg, C., Kluth, M., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Steurer, S., Clauditz, T. S., Luebke, A. M., Burandt, E., Wilczak, W., Hinsch, A., Dum, D., Beyer, B., Steuber, T., Huland, H., Graefen, M., Simon, R., Sauter, G., Melling, N., Schlomm, T. & Minner, S., 01.03.2019, In: ONCOTARGET. 10, 18, p. 1729-1744 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. 2018
  14. Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients

    Samsen, A., von der Heyde, S., Bokemeyer, C., David, K. A., Flath, B., Graap, M., Grebenstein, B., Heflik, L., Hollburg, W., Layer, P., von Leitner, E., Overkamp, F., Saeger, W., Schneider, S., von Seydewitz, C-U., Stang, A., Stein, A., Zornig, C. & Juhl, H., 05.10.2018, In: ONCOTARGET. 9, 78, p. 34794-34809 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Liver metastasis of pancreatic Cancer: the hepatic microenvironment impacts differentiation and self-renewal capacity of pancreatic ductal epithelial cells

    Knaack, H., Lenk, L., Philipp, L-M., Miarka, L., Rahn, S., Viol, F., Hauser, C., Egberts, J-H., Gundlach, J-P., Will, O., Tiwari, S., Mikulits, W., Schumacher, U., Hengstler, J. G. & Sebens, S., 03.08.2018, In: ONCOTARGET. 9, 60, p. 31771-31786 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Characterization and diagnostic application of genomic fusion sequences in anaplastic large-cell lymphoma

    Krumbholz, M., Woessmann, W., Zierk, J., Seniuk, D., Ceppi, P., Zimmermann, M., Singh, V. K., Metzler, M. & Damm-Welk, C., 29.05.2018, In: ONCOTARGET. 9, 41, p. 26543-26555 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients

    Marx, S., Splittstöhser, M., Kinnen, F., Moritz, E., Joseph, C., Paul, S., Paland, H., Seifert, C., Marx, M., Böhm, A., Schwedhelm, E., Holzer, K., Singer, S., Ritter, C. A., Bien-Möller, S., Schroeder, H. W. S. & Rauch, B. H., 25.05.2018, In: ONCOTARGET. 9, 40, p. 25860-25876 17 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians

    Kähler, K., Blome, C., Forschner, A., Gutzmer, R., Hauschild, A., Heinzerling, L., Livingstone, E., Loquai, C., Müller-Brenne, T., Schadendorf, D., Utikal, J., Wagner, T. & Augustin, M., 25.05.2018, In: ONCOTARGET. 9, 40, p. 26217-26225 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. A comparison of arterial spin labeling and dynamic susceptibility perfusion imaging for resection control in glioblastoma surgery

    Lindner, T., Ahmeti, H., Juhasz, J., Helle, M., Jansen, O., Synowitz, M. & Ulmer, S., 06.04.2018, In: ONCOTARGET. 9, 26, p. 18570-18577 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects and poor outcome in patients with advanced head and neck squamous cell carcinoma

    Verhagen, C. V. M., Vossen, D. M., Borgmann, K., Hageman, F., Grénman, R., Verwijs-Janssen, M., Mout, L., Kluin, R. J. C., Nieuwland, M., Severson, T. M., Velds, A., Kerkhoven, R., O'Connor, M. J., van der Heijden, M., van Velthuysen, M-L., Verheij, M., Wreesmann, V. B., Wessels, L. F. A., van den Brekel, M. W. M. & Vens, C., 06.04.2018, In: ONCOTARGET. 9, 26, p. 18198-18213 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer

    Dyshlovoy, S. A., Otte, K., Tabakmakher, K. M., Hauschild, J., Makarieva, T. N., Shubina, L. K., Fedorov, S. N., Bokemeyer, C., Stonik, V. A. & von Amsberg, G., 30.03.2018, In: ONCOTARGET. 9, 24, p. 16962-16973 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. 2017
  23. Multi-color RGB marking enables clonality assessment of liver tumors in a murine xenograft model

    Thomaschewski, M., Riecken, K., Unrau, L., Volz, T., Cornils, K., Ittrich, H., Heim, D., Wege, H., Akgün, E., Lütgehetmann, M., Dieckhoff, J., Köpke, M., Dandri, M., Benten, D. & Fehse, B., 29.12.2017, In: ONCOTARGET. 8, 70, p. 115582-115595 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Strong fascin expression promotes metastasis independent of its F-actin bundling activity

    Heinz, L. S., Muhs, S., Schiewek, J., Grüb, S., Nalaskowski, M., Lin, Y-N., Wikman, H., Oliveira-Ferrer, L., Lange, T., Wellbrock, J., Konietzny, A., Mikhaylova, M. & Windhorst, S., 15.12.2017, In: ONCOTARGET. 8, 66, p. 110077-110091 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines

    Ziemann, F., Seltzsam, S., Dreffke, K., Preising, S., Arenz, A., Subtil, F. S. B., Rieckmann, T., Engenhart-Cabillic, R., Dikomey, E. & Wittig, A., 01.12.2017, In: ONCOTARGET. 8, 62, p. 105170-105183 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. ABR, a novel inducer of transcription factor C/EBPα, contributes to myeloid differentiation and is a favorable prognostic factor in acute myeloid leukemia

    Namasu, C. Y., Katzerke, C., Bräuer-Hartmann, D., Wurm, A. A., Gerloff, D., Hartmann, J-U., Schwind, S., Müller-Tidow, C., Hilger, N., Fricke, S., Christopeit, M., Niederwieser, D. & Behre, G., 28.11.2017, In: ONCOTARGET. 8, 61, p. 103626-103639 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

    Jiao, X., Aravidis, C., Marikkannu, R., Rantala, J., Picelli, S., Adamovic, T., Liu, T., Maguire, P., Kremeyer, B., Luo, L., von Holst, S., Kontham, V., Thutkawkorapin, J., Margolin, S., Du, Q., Lundin, J., Michailidou, K., Bolla, M. K., Wang, Q., Dennis, J., Lush, M., Ambrosone, C. B., Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Arndt, V., Beckmann, M. W., Blomqvist, C., Blot, W., Boeckx, B., Bojesen, S. E., Bonanni, B., Brand, J. S., Brauch, H., Brenner, H., Broeks, A., Brüning, T., Burwinkel, B., Cai, Q., Chang-Claude, J., Couch, F. J., Cox, A., Cross, S. S., Deming-Halverson, S. L., Devilee, P., Dos-Santos-Silva, I., Dörk, T., Eriksson, M., Fasching, P. A., Figueroa, J., Flesch-Janys, D., Flyger, H., Gabrielson, M., García-Closas, M., Giles, G. G., González-Neira, A., Guénel, P., Guo, Q., Gündert, M., Haiman, C. A., Hallberg, E., Hamann, U., Harrington, P., Hooning, M. J., Hopper, J. L., Huang, G., Jakubowska, A., Jones, M. E., Kerin, M. J., Kosma, V-M., Kristensen, V. N., Lambrechts, D., Le Marchand, L., Lubinski, J., Mannermaa, A., Martens, J. W. M., Meindl, A., Milne, R. L., Mulligan, A. M., Neuhausen, S. L., Nevanlinna, H., Peto, J., Pylkäs, K., Radice, P., Rhenius, V., Sawyer, E. J., Schmidt, M. K., Schmutzler, R. K., Seynaeve, C., Shah, M., Simard, J., Southey, M. C., Swerdlow, A. J., Truong, T., Wendt, C., Winqvist, R., Zheng, W., Benitez, J., Dunning, A. M., Pharoah, P. D. P., Easton, D. F., Czene, K., Hall, P., Lindblom, A. & NBCS Collaborators, 28.11.2017, In: ONCOTARGET. 8, 61, p. 102769-102782 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. The shedded ectodomain of Lyve-1 expressed on M2-like tumorassociated macrophages inhibits melanoma cell proliferation

    Dollt, C., Becker, K., Michel, J., Melchers, S., Weis, C-A., Schledzewski, K., Krewer, A., Kloss, L., Gebhardt, C., Utikal, J. & Schmieder, A., 28.11.2017, In: ONCOTARGET. 8, 61, p. 103682-103692 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients

    Avril, S., Dincer, Y., Malinowsky, K., Wolff, C., Gündisch, S., Hapfelmeier, A., Boxberg, M., Bronger, H., Becker, K-F. & Schmalfeldt, B., 17.11.2017, In: ONCOTARGET. 8, 58, p. 97851-97861 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection

    von Felden, J., Schulze, K., Krech, T., Ewald, F., Nashan, B., Pantel, K., Lohse, A. W., Riethdorf, S. & Wege, H., 27.10.2017, In: ONCOTARGET. 8, 52, p. 89978-89987 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia

    Steeghs, E. M. P., Jerchel, I. S., de Goffau-Nobel, W., Hoogkamer, A. Q., Boer, J. M., Boeree, A., van de Ven, C., Koudijs, M. J., Besselink, N. J. M., de Groot-Kruseman, H. A., Zwaan, C. M., Horstmann, M. A., Pieters, R. & den Boer, M. L., 27.10.2017, In: ONCOTARGET. 8, 52, p. 89923-89938 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Sensitization of neuroblastoma for vincristine-induced apoptosis by Smac mimetic LCL161 is attended by G2 cell cycle arrest but is independent of NFκB, RIP1 and TNF-α

    Langemann, D., Trochimiuk, M., Appl, B., Hundsdoerfer, P., Reinshagen, K. & Eschenburg, G., 20.10.2017, In: ONCOTARGET. 8, 50, p. 87763-87772 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial

    Schmitt, M., Hückelhoven, A. G., Hundemer, M., Schmitt, A., Lipp, S., Emde, M., Salwender, H., Hänel, M., Weisel, K., Bertsch, U., Dürig, J., Ho, A. D., Blau, I. W., Goldschmidt, H., Seckinger, A. & Hose, D., 17.10.2017, In: ONCOTARGET. 8, 49, p. 84847-84862 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer

    Prieske, K., Prieske, S., Joosse, S. A., Trillsch, F., Grimm, D., Burandt, E., Mahner, S., Schmalfeldt, B., Milde-Langosch, K., Oliveira-Ferrer, L. & Woelber, L., 10.10.2017, In: ONCOTARGET. 8, 47, p. 83063-83074 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors

    Moreno, N., Holsten, T., Mertins, J., Zoghbi, A., Johann, P-D., Kool, M., Meisterernst, M. & Kerl, K., 10.2017, In: ONCOTARGET. 8, 49, p. 84986-84995

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

  36. AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancer

    Kripp, M., Prasnikar, N., Vehling-Kaiser, U., Quidde, J., Al-Batran, S-E., Stein, A., Neben, K., Hannig, C. V., Tessen, H. W., Trarbach, T., Hinke, A. & Hofheinz, R-D., 23.09.2017, In: ONCOTARGET. 8, 62, p. 105061-105071 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Immunotherapy of WAP-TNP mice with early stage mammary gland tumors

    Bruns, M. & Deppert, W., 15.09.2017, In: ONCOTARGET. 8, 40, p. 67790-67804

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. 11C-choline PET/CT and whole-body MRI including diffusion-weighted imaging for patients with recurrent prostate cancer

    Wieder, H., Beer, A. J., Holzapfel, K., Henninger, M., Maurer, T., Schwarzenboeck, S., Rummeny, E. J., Eiber, M. & Stollfuss, J., 12.09.2017, In: ONCOTARGET. 8, 39, p. 66516-66527 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

  39. PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort

    Lotan, T. L., Heumann, A., Rico, S. D., Hicks, J., Lecksell, K., Koop, C., Sauter, G., Schlomm, T. & Simon, R., 12.09.2017, In: ONCOTARGET. 8, 39, p. 65566-65576 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Soluble chemokine (C-X-C motif) ligand 16 (CXCL16) in urine as a novel biomarker candidate to identify high-grade urothelial carcinoma.

    Lang, K., Bonberg, N., Robens, S., Behrens, T., Hovanec, J., Deix, T., Braun, K., Roghmann, F., Noldus, J., Harth, V., Jöckel, K-H., Erbel, R., Yu Cham, T., Tannapfel, A., Käfferlein, H. U. & Brüning, T., 08.09.2017, In: ONCOTARGET. 8, 62, p. 104946-59 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Comparative study of whole genome amplification and next generation sequencing performance of single cancer cells

    Babayan, A., Alawi, M., Gormley, M., Müller, V., Wikman, H., McMullin, R. P., Smirnov, D. A., Li, W., Geffken, M., Pantel, K. & Joosse, S. A., 22.08.2017, In: ONCOTARGET. 8, 34, p. 56066-56080 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study

    Soave, A., Chun, F. K-H., Hillebrand, T., Rink, M., Weisbach, L., Steinbach, B., Fisch, M., Pantel, K. & Schwarzenbach, H., 22.08.2017, In: ONCOTARGET. 8, 34, p. 56398-56407 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. EB1 protein alteration characterizes sporadic but not ulcerative colitis associated colorectal cancer

    Gemoll, T., Kollbeck, S. L., Karstens, K. F., Hò, G. G., Hartwig, S., Strohkamp, S., Schillo, K., Thorns, C., Oberländer, M., Kalies, K., Lehr, S. & Habermann, J. K., 15.08.2017, In: ONCOTARGET. 8, 33, p. 54939-54950 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Prevention of colitis-associated cancer by selective targeting of immunoproteasome subunit LMP7

    Vachharajani, N., Joeris, T., Luu, M., Hartmann, S., Pautz, S., Jenike, E., Pantazis, G., Prinz, I., Hofer, M. J., Steinhoff, U. & Visekruna, A., 01.08.2017, In: ONCOTARGET. 8, 31, p. 50447-50459 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Implementing liquid biopsies into clinical decision making for cancer immunotherapy

    Quandt, D., Dieter Zucht, H., Amann, A., Wulf-Goldenberg, A., Borrebaeck, C., Cannarile, M., Lambrechts, D., Oberacher, H., Garrett, J., Nayak, T., Kazinski, M., Massie, C., Schwarzenbach, H., Maio, M., Prins, R., Wendik, B., Hockett, R., Enderle, D., Noerholm, M., Hendriks, H., Zwierzina, H. & Seliger, B., 18.07.2017, In: ONCOTARGET. 8, 29, p. 48507-48520 14 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  46. A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and "pan-leukemia" antigens: entity-specific dividing lines and "pan-leukemia" antigens

    Backert, L., Kowalewski, D. J., Walz, S., Schuster, H., Berlin, C., Neidert, M. C., Schemionek, M., Brümmendorf, T. H., Vucinic, V., Niederwieser, D., Kanz, L., Salih, H. R., Kohlbacher, O., Weisel, K., Rammensee, H-G., Stevanovic, S. & Walz, J. S., 04.07.2017, In: ONCOTARGET. 8, 27, p. 43915-43924 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Functional characterization of the lysosomal membrane protein TMEM192 in mice

    Nguyen, T. L., Schneppenheim, J., Rudnik, S., Lüllmann-Rauch, R., Bernreuther, C., Hermans-Borgmeyer, I., Glatzel, M., Saftig, P. & Schröder, B., 04.07.2017, In: ONCOTARGET. 8, 27, p. 43635-43652 18 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients

    Kuerti, S., Oliveira-Ferrer, L., Milde-Langosch, K., Schmalfeldt, B., Legler, K., Woelber, L., Prieske, K., Mahner, S. & Trillsch, F., 27.06.2017, In: ONCOTARGET. 8, 26, p. 43218-43227

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

    Burdelski, C., Borcherding, L., Kluth, M., Hube-Magg, C., Melling, N., Simon, R., Möller-Koop, C., Weigand, P., Minner, S., Haese, A., Michl, H. U., Tsourlakis, M. C., Jacobsen, F., Hinsch, A., Wittmer, C., Lebok, P., Steurer, S., Izbicki, J. R., Sauter, G., Krech, T., Büscheck, F., Clauditz, T., Schlomm, T. & Wilczak, W., 09.05.2017, In: ONCOTARGET. 8, 19, p. 31494-31508 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia

    Latuske, E-M., Stamm, H., Klokow, M., Vohwinkel, G., Muschhammer, J., Bokemeyer, C., Jücker, M., Kebenko, M., Fiedler, W. & Wellbrock, J., 25.04.2017, In: ONCOTARGET. 8, 17, p. 29187-29201

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

    Fagerholm, R., Khan, S., Schmidt, M. K., García-Closas, M., Heikkilä, P., Saarela, J., Beesley, J., Jamshidi, M., Aittomäki, K., Liu, J., Ali, H. R., Andrulis, I. L., Beckmann, M. W., Behrens, S., Blows, F. M., Brenner, H., Chang-Claude, J., Couch, F. J., Czene, K., Fasching, P. A., Figueroa, J., Floris, G., Glendon, G., Guo, Q., Hall, P., Hallberg, E., Hamann, U., Holleczek, B., Hooning, M. J., Hopper, J. L., Jager, A., Kabisch, M., Keeman, R., Kosma, V-M., Lambrechts, D., Lindblom, A., Mannermaa, A., Margolin, S., Provenzano, E., Shah, M., Southey, M. C., Dennis, J., Lush, M., Michailidou, K., Wang, Q., Bolla, M. K., Dunning, A. M., Easton, D. F., Pharoah, P. P. D., Chenevix-Trench, G., Blomqvist, C., Nevanlinna, H. & kConFab/AOCS Investigators, 14.03.2017, In: ONCOTARGET. 8, 11, p. 18381-18398 18 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

    Kluth, M., Ahrary, R., Hube-Magg, C., Ahmed, M., Volta, H., Schwemin, C., Steurer, S., Wittmer, C., Wilczak, W., Burandt, E., Krech, T., Adam, M., Michl, U., Heinzer, H., Salomon, G., Graefen, M., Koop, C., Minner, S., Simon, R., Sauter, G. & Schlomm, T., 10.01.2017, In: ONCOTARGET. 8, 2, p. 3761

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  53. Deletion of 8p is an independent prognostic parameter in prostate cancer

    Kluth, M., Amschler, N. N., Galal, R., Möller-Koop, C., Barrow, P., Tsourlakis, M. C., Jacobsen, F., Hinsch, A., Wittmer, C., Steurer, S., Krech, T., Büscheck, F., Clauditz, T. S., Beyer, B., Wilczak, W., Graefen, M., Huland, H., Minner, S., Schlomm, T., Sauter, G. & Simon, R., 03.01.2017, In: ONCOTARGET. 8, 1, p. 379-392 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression

    Hohensee, I., Chuang, H-N., Grottke, A., Werner, S., Schulte, A., Horn, S., Lamszus, K., Bartkowiak, K., Witzel, I., Westphal, M., Matschke, J., Glatzel, M., Jücker, M., Pukrop, T., Pantel, K. & Wikman, H., 01.2017, In: ONCOTARGET. 8, 4, p. 6155-6168

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 3 Next